Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

AQST

Aquestive Therapeutics (AQST)

Aquestive Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AQST
DateTimeSourceHeadlineSymbolCompany
28/05/202422:00GlobeNewswire Inc.Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data At 2024 Eastern Allergy ConferenceNASDAQ:AQSTAquestive Therapeutics Inc
14/05/202403:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
14/05/202403:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
09/05/202422:00GlobeNewswire Inc.Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences ConferenceNASDAQ:AQSTAquestive Therapeutics Inc
08/05/202406:23Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AQSTAquestive Therapeutics Inc
08/05/202406:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
08/05/202406:19GlobeNewswire Inc.Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:AQSTAquestive Therapeutics Inc
29/04/202421:00GlobeNewswire Inc.Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual FilmNASDAQ:AQSTAquestive Therapeutics Inc
25/04/202422:00GlobeNewswire Inc.Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ETNASDAQ:AQSTAquestive Therapeutics Inc
13/04/202406:01GlobeNewswire Inc.Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of NeurologyNASDAQ:AQSTAquestive Therapeutics Inc
01/04/202423:00GlobeNewswire Inc.Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech ExecutiveNASDAQ:AQSTAquestive Therapeutics Inc
25/03/202423:00GlobeNewswire Inc.Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common StockNASDAQ:AQSTAquestive Therapeutics Inc
20/03/202412:49GlobeNewswire Inc.Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common StockNASDAQ:AQSTAquestive Therapeutics Inc
20/03/202407:01GlobeNewswire Inc.Aquestive Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:AQSTAquestive Therapeutics Inc
15/03/202408:23GlobeNewswire Inc.Aquestive Therapeutics Announces Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Successfully Meets Primary and Secondary Endpoints and Provides Clinical Development Update Following FDA MeetingNASDAQ:AQSTAquestive Therapeutics Inc
12/03/202401:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
12/03/202401:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
12/03/202401:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
12/03/202401:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
12/03/202401:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
12/03/202401:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
12/03/202401:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
09/03/202408:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
06/03/202409:12Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:AQSTAquestive Therapeutics Inc
06/03/202409:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
06/03/202409:05GlobeNewswire Inc.Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:AQSTAquestive Therapeutics Inc
22/02/202400:00GlobeNewswire Inc.Aquestive Therapeutics to Report Fourth Quarter 2023 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ETNASDAQ:AQSTAquestive Therapeutics Inc
16/02/202400:00GlobeNewswire Inc.Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data at the 2024 AAAAI Annual MeetingNASDAQ:AQSTAquestive Therapeutics Inc
15/02/202407:24Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AQSTAquestive Therapeutics Inc
13/02/202409:02Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AQSTAquestive Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:AQST